Matthew Lee, MD
Orthopaedic Surgery · Tallahassee, FLNPI 1386705283
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $61,702 of the $76,962 with a category attached, or 80.2%. Medtronic accounts for 90.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $44,636 and has fallen 99.5% since, to $236 in 2025.
Across 124 payments — averaging $620.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$69K
- CGG Medical Inc$5K
- Si-bone, Inc.$2K
- Arthrex$601
- Bioventus LLC$145
- Abbott$113
- plus $213 from 8 others
Across 5 payments — averaging $4381.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$22K
What the payments were for
- Consulting fees$1,6002%
- Speaking & faculty fees$61,70280%
- Travel & lodging$9,65513%
- Food & beverage$4,0065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 83 | $69,325 |
| CGG Medical Inc | 14 | $4,628 |
| Si-bone, Inc. | 7 | $1,937 |
| Arthrex | 9 | $601 |
| Bioventus LLC | 2 | $145 |
| Abbott | 1 | $113 |
| Stryker | 1 | $77 |
| GSK | 1 | $34 |
| Zyla Life Sciences, Inc. | 1 | $24 |
| Globus Medical | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $19 |
| Amgen | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Karyopharm Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DIVERGENCE-L$28,105
- PIVOX Oblique Lateral Spinal System$19,801
- CLYDESDALE$14,444
- IFUSE IMPLANT SYSTEM$1,600
- CD HORIZON SPINAL SYSTEM$130
- iFuse Implant$125
- Durolane$120
- ETERNA$113
- O-ARM-Spine$105
How this compares
$76,962 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 314 | $4,119 |
| Tizanidine Hcl | 201 | $2,218 |
| Oxycodone Hcl | 101 | $1,111 |
| Celecoxib | 42 | $863 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $388 |
| Methylprednisolone | 37 | $369 |
| Pregabalin | 27 | $342 |
| Nabumetone | 34 | $321 |
| Naproxen | 20 | $234 |
| Diclofenac Sodium | 12 | $210 |
| Meloxicam | 52 | $189 |
| Cyclobenzaprine Hcl | 20 | $125 |
| Hydromorphone Hcl | 17 | $111 |
| Tramadol Hcl | 26 | $101 |
| Alprazolam | 18 | $25 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tallahassee
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.